Maureen Pearce, CRNP Clinical Nurse Specialist - Family Health Medicare: Accepting Medicare Assignments Practice Location: 600 Clements Bridge Rd, Wound Healing Solutions Pa And De Llc, Barrington, NJ 08007 Phone: 856-547-8000 Fax: 856-547-1008 |
News Archive
Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
As political leaders debate the future of the U.S. health care system, a pair of health financing experts discovered that all of the current proposals - from Medicare for All to "repeal and replace" - have been circulating in various forms since the 1940s.
In rather disconcerting news, it appears that as many as one in 25 fathers, could unwittingly be raising another man's child.
Alexion Pharmaceuticals, Inc. today announced presentation of data showing that the presence of Type II paroxysmal nocturnal hemoglobinuria (PNH) cells is correlated with thrombocytopenia, potentially indicating that patients with Type II cells experience ongoing platelet consumption and increased thrombosis risk.
› Verified 2 days ago